These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 26785333)

  • 1. Eltrombopag for Treatment of Thrombocytopenia after Allogeneic Hematopoietic Cell Transplantation.
    Tanaka T; Inamoto Y; Yamashita T; Fuji S; Okinaka K; Kurosawa S; Kim SW; Tanosaki R; Fukuda T
    Biol Blood Marrow Transplant; 2016 May; 22(5):919-24. PubMed ID: 26785333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombopoietin Receptor Agonists for Severe Thrombocytopenia after Allogeneic Stem Cell Transplantation: Experience of the Spanish Group of Hematopoietic Stem Cell Transplant.
    Bento L; Bastida JM; García-Cadenas I; García-Torres E; Rivera D; Bosch-Vilaseca A; De Miguel C; Martínez-Muñoz ME; Fernández-Avilés F; Roldán E; Chinea A; Yáñez L; Zudaire T; Vaz CP; Espigado I; López J; Valcárcel D; Duarte R; Cabrera R; Herrera C; González-Porras JR; Gutiérrez A; Solano C; Sampol A;
    Biol Blood Marrow Transplant; 2019 Sep; 25(9):1825-1831. PubMed ID: 31152794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eltrombopag treatment in thrombocytopenia following hematopoietic stem cell transplantation: A multicenter real-world experience.
    Kilic Gunes E; Yigit Kaya S; Yaman F; Yeniay MK; Vural K; Comert M; Sevindik OG; Andic N; Dagdas S; Nizam Ozen I; Kaynar L; Yavasoglu F; Ozet G; Karakus V; Ayli M
    Leuk Res; 2024 May; 140():107484. PubMed ID: 38520796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eltrombopag for Delayed Platelet Recovery and Secondary Thrombocytopenia Following Allogeneic Stem Cell Transplantation in Children.
    Li S; Wu R; Wang B; Fu L; Zhu G; Zhou X; Ma J; Zhang L; Qin M
    J Pediatr Hematol Oncol; 2019 Jan; 41(1):38-41. PubMed ID: 30080752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eltrombopag for Treating Thrombocytopenia after Allogeneic Stem Cell Transplantation.
    Yuan C; Boyd AM; Nelson J; Patel RD; Varela JC; Goldstein SC; Ahmad S; Zhu X; Mori S
    Biol Blood Marrow Transplant; 2019 Jul; 25(7):1320-1324. PubMed ID: 30710685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eltrombopag for thrombocytopenia following allogeneic hematopoietic stem cell transplantation in children.
    Masetti R; Vendemini F; Quarello P; Girardi K; Prete A; Fagioli F; Pession A; Locatelli F
    Pediatr Blood Cancer; 2020 May; 67(5):e28208. PubMed ID: 32065469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of anti-thrombopoietin receptor antibody in prolonged thrombocytopenia after allogeneic hematopoietic stem cell transplantation treated successfully with eltrombopag.
    Fujimi A; Kamihara Y; Hashimoto A; Kanisawa Y; Nakajima C; Hayasaka N; Yamada S; Okuda T; Minami S; Ono K; Iyama S; Kato J
    Int J Hematol; 2015 Oct; 102(4):471-6. PubMed ID: 25964100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eltrombopag for treatment of thrombocytopenia after allogeneic hematopoietic cell transplantation in children: Single-centre experience.
    Yaman Y; Elli M; Şahin Ş; Özdilli K; Bilgen H; Bayram N; Nepesov S; Anak S
    Pediatr Transplant; 2021 Aug; 25(5):e13962. PubMed ID: 33452850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eltrombopag in the treatment of patients with persistent thrombocytopenia after haploidentical peripheral blood stem cell transplantation: a single-center experience.
    Yan F; Lu N; Gu Z; Huang W; Wang S; Gao X; Dou L; Li F; Wang L; Li M; Liu D; Gao C
    Ann Hematol; 2022 Feb; 101(2):397-408. PubMed ID: 34735613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eltrombopag treatment promotes platelet recovery and reduces platelet transfusion for patients with post-transplantation thrombocytopenia.
    Gao F; Zhou X; Shi J; Luo Y; Tan Y; Fu H; Lai X; Yu J; Huang H; Zhao Y
    Ann Hematol; 2020 Nov; 99(11):2679-2687. PubMed ID: 32519094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eltrombopag for Treatment of Thrombocytopenia Following Hematopoietic Stem Cell Transplantation.
    Güven ZT; Çelik S; Eser B; Çetin M; Ünal A; Kaynar L
    Turk J Haematol; 2022 Jun; 39(2):103-108. PubMed ID: 35297243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of eltrombopag in thrombocytopenia after hematopoietic stem celltransplantation.
    Karataş A; Göker H; Demiroğlu H; Malkan ÜY; Velet M; Çınar OE; Erdoğdu B; Karadeniz M; Sayınalp N; Aksu S; Haznedaroğlu İC; Özcebe Oİ; Büyükaşık Y
    Turk J Med Sci; 2022 Apr; 52(2):413-419. PubMed ID: 36161632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Thrombopoietin Receptor Agonists in Prolonged Thrombocytopenia after Hematopoietic Stem Cell Transplantation.
    Mahat U; Rotz SJ; Hanna R
    Biol Blood Marrow Transplant; 2020 Mar; 26(3):e65-e73. PubMed ID: 31830528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eltrombopag as first-line treatment for thrombocytopenia among paediatric patients after allogeneic haematopoietic stem cell transplantation.
    Qiu KY; Liao XY; Huang K; Wu RH; Xu HG; Xu LH; Li Y; Weng WJ; Zhou DH; Fang JP
    Br J Clin Pharmacol; 2021 Apr; 87(4):2023-2031. PubMed ID: 33080064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eltrombopag for secondary failure of platelet recovery post-allogeneic hematopoietic stem cell transplant in children.
    Ali S; Gassas A; Kirby-Allen M; Krueger J; Ali M; Schechter T
    Pediatr Transplant; 2017 Sep; 21(6):. PubMed ID: 28653480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of eltrombopag in Japanese patients with chronic liver disease and thrombocytopenia: a randomized, open-label, phase II study.
    Kawaguchi T; Komori A; Seike M; Fujiyama S; Watanabe H; Tanaka M; Sakisaka S; Nakamuta M; Sasaki Y; Oketani M; Hattori T; Katsura K; Sata M
    J Gastroenterol; 2012 Dec; 47(12):1342-51. PubMed ID: 22674141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of eltrombopag for treating thrombocytopenia after allogeneic stem cell transplantation.
    Rivera D; Bastida JM; Lopez-Corral L; Sanchez-Guijo F; Cabrero M; Martin A; Perez E; Lopez-Parra M; Avendaño A; Veiga A; Baile M; Arratibel N; Carrillo J; Vazquez L; Caballero MD; Gonzalez-Porras JR
    Bone Marrow Transplant; 2019 May; 54(5):757-761. PubMed ID: 30356164
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful eltrombopag treatment of severe refractory thrombocytopenia in chronic myelomonocytic leukemia: Two cases reports: A CARE-compliant article.
    Gao Y; Gong M; Zhang C; Kong X; Ma Y
    Medicine (Baltimore); 2017 Oct; 96(43):e8337. PubMed ID: 29069007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial.
    Grainger JD; Locatelli F; Chotsampancharoen T; Donyush E; Pongtanakul B; Komvilaisak P; Sosothikul D; Drelichman G; Sirachainan N; Holzhauer S; Lebedev V; Lemons R; Pospisilova D; Ramenghi U; Bussel JB; Bakshi KK; Iyengar M; Chan GW; Chagin KD; Theodore D; Marcello LM; Bailey CK
    Lancet; 2015 Oct; 386(10004):1649-58. PubMed ID: 26231455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of eltrombopag, a thrombopoietin receptor agonist, in post-transplantation thrombocytopenia.
    Reid R; Bennett JM; Becker M; Chen Y; Milner L; Phillips GL; Liesveld J
    Am J Hematol; 2012 Jul; 87(7):743-5. PubMed ID: 22573520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.